Notice of Closed Meeting, 3157-3158 [2021-00572]
Download as PDF
<![CDATA[
3157
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
training. Post-test measures will be
collected the week of the training (week
three of the study), one week after the
training (week four) and at eight and
nine weeks after the training (weeks 11
and 12 of the study). Additional posttest measures will include feedback
about the training and if specific
behaviors changed.
Before starting the pretest, the
respondent will sign an informed
consent form. The pilot pre-test will
start with the respondent filling out a 10
minute online survey that includes four
short surveys: (1) Demographic
information and work experience; (2)
the Epworth Sleepiness Scale; (3) the
Pittsburgh Sleep Quality Index; and (4)
a knowledge test. The respondent will
be fitted with a wrist actigraph, which
will record activity and estimate the
times of sleep. The respondents will
keep an online sleep activity diary and
wear the actigraph continuously during
weeks one to four of the study. The
online sleep activity diary takes
approximately two minutes a day to
complete. The sleep diary and actigraph
are being used together to obtain a more
accurate timing of respondent’s sleep
and activity.
During the third week of the study,
the respondent will take the 2.5 hour
online training program. Immediately
after completing the training, the
respondent will take the post-test
knowledge test and will provide
feedback about the training including
barriers to using the training
information and what influential people
in their life would want them to do with
the training information. At the end of
week four, the respondent will return
the actigraph. No data collection will
occur during weeks five to 10 of the
study.
The second post-test period will be
weeks 11 and 12 of the study to gather
longer-term outcomes. At the beginning
of week 11, the respondents will be
fitted with an actigraph. The respondent
will wear the actigraph and complete
the sleep activity diary for the next 14
days. At the end of week 12 of the
study, the respondent will complete the
Epworth Sleepiness Scale, Pittsburgh
Sleep Quality Index, and Changes in
Behaviors After Training. The combined
response time is five minutes.
The burden table lists three 10-minute
meetings during the post-test period
when they will return the actigraph at
the end of week four, be fitted with an
actigraph at the beginning of week 11
and return it at the end of week 12. The
respondents will complete the sleep
activity diary for 42 days total (two
minutes each day). The total burden
hours for the diary is 84.
Study staff will use the findings from
the pilot test to make improvements to
the training program. The research team
will reinforce or expand training
content that showed less than desired
results on the pilot test. Potential
impacts of this project include
improvements in management practices
such as the design of work schedules
and improvements in officers’ personal
behaviors for coping with the demands
of shift work and long work hours. The
total estimated annualized burden hours
is 334. There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Law enforcement officers ................................
phone call for recruitment & informed consent.
Initial meeting .................................................
Knowledge survey ..........................................
Epworth Sleepiness Scale .............................
Pittsburgh Sleep Quality Index ......................
Demographics and work experience .............
Sleep diary .....................................................
Online training ................................................
Feedback about Training, Barriers, and Influential People.
Changes in Behaviors after Training .............
Actigraph fitting and return .............................
Law
Law
Law
Law
Law
Law
Law
Law
enforcement
enforcement
enforcement
enforcement
enforcement
enforcement
enforcement
enforcement
officers
officers
officers
officers
officers
officers
officers
officers
................................
................................
................................
................................
................................
................................
................................
................................
Law enforcement officers ................................
Law enforcement officers ................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–00690 Filed 1–13–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
60
1
30/60
60
60
60
60
60
60
60
60
1
2
2
2
1
42
1
1
15/60
5/60
1/60
2/60
2/60
2/60
150/60
5/60
60
60
1
3
2/60
10/60
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
Notice of Funding Opportunity (NOFO)
DP21–003, Reducing Inequities in
Cancer Outcomes through CommunityBased Interventions on Social
Determinants of Health.
Date: April 6, 2021–April 8, 2021.
Time: 10:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
Jaya
Raman Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop
F80, Atlanta, Georgia 30341, Telephone:
(770) 488–6511, JRaman@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\14JAN1.SGM
14JAN1
3158
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–00572 Filed 1–13–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–43 and CMS–
381]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by February 16, 2021.
DATES:
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Application for
Health Insurance Benefits Under
Medicare for Individual with Chronic
Renal Disease and Supporting
Regulations in 42 CFR; Use: Individuals
with End-Stage Renal Disease (ESRD)
have the opportunity to apply for
Medicare benefits and obtain premiumfree Part A if they meet certain criteria
outlined in statute. Sections 226A of the
Act authorizes entitlement for Medicare
Hospital Insurance (Part A) if the
individual with ESRD files an
application for benefits and meets the
requisite contributions through one’s
ADDRESSES:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
own employment or the employment of
a related individual to meet the
statutory definition of a ‘‘currently
insured’’ individual outlined in section
214 of the Act. Further, for individuals
who meet the requirements for
premium-free Part A entitlement,
Medicare coverage starts based on the
dates in which the individual started
dialysis treatment or had a kidney
transplant. These statutory provisions
are codified at 42 CFR 406.7(c)(3) and
407.13.
The CMS–43 form is used (in
conjunction with the CMS–2728, OMB
control number 0938–0046) to establish
entitlement to Medicare Part A and
enrollment in Medicare Part B for
individuals with ESRD. Form CMS–43
is only used for initial applications for
Medicare by individuals diagnosed with
ESRD. Form CMS–2728 provides the
medical documentation that the
individual has ESRD, and it
accompanies Form CMS–43.
Form CMS–43 is completed by the
person applying for Medicare or by an
SSA representative using information
provided by the Medicare enrollee
during an in-person interview. The
majority of the forms are completed by
an SSA representative on behalf of the
individual applying for Medicare
benefits. Form Number: CMS–43 (OMB
control number: 0938–0080); Frequency:
Yearly; Affected Public: State, Local, or
Tribal Governments; Number of
Respondents: 20,382; Total Annual
Responses: 20,382; Total Annual Hours:
8,560. (For policy questions regarding
this collection contact Carla Patterson at
410–786–1000.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Identification of
Extension Units of Medicare Approved
Outpatient Physical Therapy/Outpatient
Speech Pathology (OPT/OSP) Providers
and Supporting Regulations; Use: Form
CMS–381 was developed to ensure that
each OPT/OSP extension location at
which OPT/OSP providers furnish
services, must be reported by the
providers to the State Survey Agencies
(SAs). Form CMS–381 is completed
when: (1) New OPT/OSP providers
enter the Medicare program; (2) when
existing OPT/OPS providers delete or
add a service, or close or add an
extension location; or, (3) when existing
OPT/OSP providers are recertified by
the State Survey Agency every 6 years.
Form Number: CMS–381 (OMB control
number: 0938–0273); Frequency:
Occasionally; Affected Public: Private
Sector; Business or other for-profit and
not-for-profit institutions; Number of
Respondents: 2,083; Total Annual
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Pages 3157-3158]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00572]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--Notice of Funding Opportunity
(NOFO) DP21-003, Reducing Inequities in Cancer Outcomes through
Community-Based Interventions on Social Determinants of Health.
Date: April 6, 2021-April 8, 2021.
Time: 10:00 a.m.-6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
FOR FURTHER INFORMATION CONTACT: Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia
30341, Telephone: (770) 488-6511, [email protected].
[[Page 3158]]
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-00572 Filed 1-13-21; 8:45 am]
BILLING CODE 4163-18-P
